Detalhe da pesquisa
1.
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma.
J Biol Chem
; 293(7): 2452-2465, 2018 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29279332
2.
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
J Immunol
; 199(5): 1933-1941, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754680
3.
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Blood
; 128(5): 680-5, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27259980
4.
TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Blood
; 123(21): 3305-15, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723682
5.
MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.
Br J Haematol
; 160(6): 779-84, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23252623
6.
A feasibility and acceptability study of screening the parents/guardians of pediatric dental patients for the social determinants of health.
Pilot Feasibility Stud
; 9(1): 36, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895054
7.
Phylogenomic analyses of the BARREN STALK1/LAX PANICLE1 (BA1/LAX1) genes and evidence for their roles during axillary meristem development.
Mol Biol Evol
; 28(7): 2147-59, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21297156
8.
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.
Cell Rep
; 40(7): 111201, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977482
9.
Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.
J Leukoc Biol
; 102(2): 265-275, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28254840
10.
Deploying myeloid cells against myeloma.
Oncoimmunology
; 5(3): e1090076, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141348
11.
Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma.
Cancer Immunol Res
; 3(8): 881-90, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25941352
12.
Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.
Leuk Lymphoma
; 60(10): 2558-2562, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30845856
13.
Macrophages in multiple myeloma: emerging concepts and therapeutic implications.
Leuk Lymphoma
; 54(10): 2112-21, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23432691